Medtech Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Virtual Colonoscopy: 55% Sensitivity Not Ready For Prime Time – JAMA Study

This article was originally published in The Gray Sheet

Executive Summary

Virtual colonoscopy should not be widely adopted until sensitivity improvements can be shown in routine practice settings, an April 14 JAMA editorial maintains

You may also be interested in...



Colorectal Cancer DNA Test Cost, Health Benefit Questioned In NEJM Editorial

Exact Sciences' PreGen-Plus fecal DNA colorectal cancer screening test should not replace fecal occult blood tests due to unanswered questions about cost and health benefits, according to a Dec. 23 New England Journal of Medicine editorial

Colorectal Cancer DNA Test Cost, Health Benefit Questioned In NEJM Editorial

Exact Sciences' PreGen-Plus fecal DNA colorectal cancer screening test should not replace fecal occult blood tests due to unanswered questions about cost and health benefits, according to a Dec. 23 New England Journal of Medicine editorial

Virtual Colonography Mirrors Standard Procedure Sensitivity Rates – IPAC

The evidence encompassing computed tomographic (CT) colonography adequately supports use of the procedure, according to UK's Interventional Procedures Advisory Committee

Related Content

Latest Headlines
See All
UsernamePublicRestriction

Register

MT020094

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel